Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

Hong Kong · Delayed Price · Currency is HKD

32.00

+0.08 (0.25%)

Jun 18, 2026, 4:08 PM HKT

28.00% (1Y)

Market Cap	6.70B +52.3%
Revenue (ttm)	1.19B +25.1%
Net Income	229.49M +14.0%
EPS	1.40 +14.2%
Shares Out	209.45M
PE Ratio	22.90
Forward PE	n/a
Dividend	0.26 (0.81%)
Ex-Dividend Date	Jun 3, 2026

Volume	156,200
Open	31.50
Previous Close	31.92
Day's Range	31.50 - 33.30
52-Week Range	20.10 - 41.40
Beta	0.07
Analysts	Strong Buy
Price Target	36.37 (+13.66%)
Earnings Date	Mar 27, 2026

About HKG:1501

Shanghai INT Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. It offers transradial and femoral pressure bandage, hydrophilic guidewire, pressure Y-connector set, PTFE guidewire, PTCA balloon dilatation catheter, noncompliant balloon dilatation catheter, compression femoral artery tourniquet, vascular sheaths for single use, push-to-thread balloon dilatio... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2006

Employees 2,088

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1501

Full Company Profile

Financial Performance

In 2025, HKG:1501's revenue was 1.07 billion, an increase of 25.06% compared to the previous year's 851.95 million. Earnings were 206.23 million, an increase of 13.99%.

Financial numbers in CNY Financial Statements